• Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
    • World Sepsis Day
  • Contact
  • en
  • sv
  • Home
  • About Us
    • About us
    • Scientific Advisory Board
    • People
    • Business Strategy
    • Event Calendar
  • Development
    • Portfolio
    • APTA-1
    • Intellectual property and patent
    • What is sepsis?
  • Market
    • Sepsis
    • Clinical application
  • Investor Relations
    • Company Information
    • Financial Information
    • Largest Shareholders
    • Financial Calendar
    • Presentations
  • News
    • World Sepsis Day
  • Contact
  • en
  • sv

Archives

Home / 2021 / November
  0
By Erika Medin
In News
Posted 3 November 2021

Aptahem has started the production of GMP certified Apta-1 for clinical trials

Aptahem can today announce that the production of Good Manufacturing Practice (GMP) manufacturing of the drug candidate Apta-1 has started at the collaboration partner LGC Biotechnologies’ [...]

READ MORE
Contact



Norra Vallgatan 58, 4 TR
211 22 Malmö
Sweden
E-mail: info@aptahem.com

Aptahem is supporting Global Sepsis Alliance
To all salesmen:

We kindly decline all direct contact with salesmen of different types of products and services.

Copyright All Rights Reserved © 2016

Start typing and press Enter to search